Back to search
FDAFDA · Food and drugs·Recall number D-1722-2019

Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg, 100-count bottle, Rx Only, Distributed by: Alvogen, Inc. Pine Brook, NY 07058 USA, NDC 47781-303-01

Published August 21, 2019 · Recall initiated: July 24, 2019

Summary

FDA records drug Class II recall D-1722-2019, published August 21, 2019 and initiated July 24, 2019. Recalling firm: Alvogen, Inc; Status: Terminated; Reported quantity: 2784 bottles; Lot: Lot # 471976, Exp 03/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE
Manufacturer
Alvogen, Inc
Distributor
Natonwide, PR
UPC
0347781303013
Lot
Lot # 471976, Exp 03/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg, 100-count bottle, Rx Only, Distributed by: Alvogen, Inc. Pine Brook, NY 07058 USA, NDC 47781-303-01 recalled?

Yes. FDA published recall D-1722-2019 on August 21, 2019. Reported hazard: Failed dissolution specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE. UPC: 0347781303013.